Piperidine → Phe-Gly

HRID 39263

Reaktionsgleichung

Reaktionsgleichung von HRID 39263
C1C2C(COC([NH:18][C@H:19]([C:27]([NH:29][CH2:30][C:31]([OH:33])=[O:32])=[O:28])[CH2:20][C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=3)=O)C3C(=CC=CC=3)C=2C=CC=1.N1CCCCC1>CN(C=O)C>[NH2:18][C@H:19]([C:27]([NH:29][CH2:30][C:31]([OH:33])=[O:32])=[O:28])[CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1

Komponenten

4

Edukt 2

HCID 8082PiperidineHCID 11328236Fmoc-Phe-Gly-OH

Produkt 1

HCID 6992304Phe-Gly

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

Fmoc-protected dipeptide 72 (500 mg, 1.00 mmol) was treated with a 5% v/v solution of piperidine in DMF (5 mL). After stirring for 1 h, the reaction mixture was concentrated to dryness. The crude material was used for the next step without purification.

Aufarbeitung

  1. concentrationthe reaction mixture was concentrated to dryness
  2. customThe crude material was used for the next step without purification

Quellen und Nachweise

ORD-Eintrag
ord-f2ae1b8090a940d2913985de4b8df854
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08524691B2

Verknüpfte Notizen

Wird geladen…